Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSV | O60911 | 3/20 | 0.86 |
| ▸ | CTSL | P07711 | 3/20 | 0.86 |
| ▸ | AKR1C3 | P42330 | 4/20 | 0.75 |
| ▸ | AKR1C2 | P52895 | 4/20 | 0.75 |
| ▸ | MAPT | P10636 | 7/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.69 |
| ▸ | MEN1 | O00255 | 5/20 | 0.69 |
| ▸ | MYC | P01106 | 1/20 | 0.63 |
| ▸ | MAX | P61244 | 1/20 | 0.63 |
| ▸ | GFER | P55789 | 3/20 | 0.60 |
| ▸ | GAA | P10253 | 2/20 | 0.58 |
| ▸ | ANO1 | Q5XXA6 | 1/20 | 0.58 |
| ▸ | ANO2 | Q9NQ90 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.54 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.54 |
| ▸ | FBP1 | P09467 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL354532 | 0.92 | CTSV (1.00) | CTSVCTSLAKR1C3AKR1C2MAPT | |
| SCHEMBL3030579 | 0.91 | CTSV (0.77) | CTSVCTSLAKR1C3AKR1C2MAPT | |
| SCHEMBL14069980 | 0.91 | CTSV (0.77) | CTSVCTSLAKR1C3AKR1C2MAPT | |
| SCHEMBL7331642 | 0.91 | CTSV (0.77) | CTSVCTSLAKR1C3AKR1C2MAPT | |
| SCHEMBL5336704 | 0.91 | CTSV (0.77) | CTSVCTSLAKR1C3AKR1C2MAPT | |
| SCHEMBL13696982 | 0.89 | CTSV (0.73) | CTSVCTSLAKR1C3AKR1C2MAPT | |
| SCHEMBL7331118 | 0.88 | CTSV (1.00) | CTSVCTSLAKR1C3AKR1C2MAPT | |
| SCHEMBL6652239 | 0.88 | CTSV (0.80) | CTSVCTSLAKR1C3AKR1C2MAPT | |
| SCHEMBL4249335 | 0.88 | CTSV (0.71) | CTSVCTSLAKR1C3AKR1C2MAPT | |
| SCHEMBL3031833 | 0.88 | CTSV (0.71) | CTSVCTSLAKR1C3AKR1C2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090131527-A1 | NOVEL ANTHRANILIC ACID DERIVATIVES AND CHLORIDE CHANNEL BLOCKING AGENT CONTAINING THE SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2009-05-21 | — | — | US | claimed |
| US-20090131527-A1 | NOVEL ANTHRANILIC ACID DERIVATIVES AND CHLORIDE CHANNEL BLOCKING AGENT CONTAINING THE SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2009-05-21 | — | — | US | disclosed |
| US-20090131527-A1 | NOVEL ANTHRANILIC ACID DERIVATIVES AND CHLORIDE CHANNEL BLOCKING AGENT CONTAINING THE SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2009-05-21 | — | — | US | disclosed |
| US-20090131527-A1 | NOVEL ANTHRANILIC ACID DERIVATIVES AND CHLORIDE CHANNEL BLOCKING AGENT CONTAINING THE SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2009-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131527-A1 | NOVEL ANTHRANILIC ACID DERIVATIVES AND CHLORIDE CHANNEL BLOCKING AGENT CONTAINING THE SAME | CLIC1, ASIC1, CLIC4 | CTSV 3420/4885CTSL 3181/4885AKR1C3 787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.